1![Finley_MSM Consortium Meeting_2013.key Finley_MSM Consortium Meeting_2013.key](https://www.pdfsearch.io/img/8af0d816c7ab843111caf7412c03d149.jpg) | Add to Reading ListSource URL: www.cse-lab.ethz.chLanguage: English - Date: 2015-10-12 08:25:52
|
---|
2![Dow Jones VentureWire Versant-Backed Inception Sciences Creates Eye-Drug Startup With Bayer Healthcare th November Dow Jones VentureWire Versant-Backed Inception Sciences Creates Eye-Drug Startup With Bayer Healthcare th November](https://www.pdfsearch.io/img/980e2c4d6a0567ad39bb13c0718c433d.jpg) | Add to Reading ListSource URL: www.versantventures.comLanguage: English - Date: 2014-01-21 19:48:19
|
---|
3![Published OnlineFirst June 1, 2011; DOI:.CCRMyeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept John F. de Groot, Yuji Piao, Hai Tran, et al. Clin Can Published OnlineFirst June 1, 2011; DOI:.CCRMyeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept John F. de Groot, Yuji Piao, Hai Tran, et al. Clin Can](https://www.pdfsearch.io/img/99a12a247c62eac26205354e1fd0c6ee.jpg) | Add to Reading ListSource URL: neurooncology.ucla.eduLanguage: English - Date: 2011-08-25 12:44:06
|
---|
4![PRESTATIE- EN TARIEFBESCHIKKING ADD-ON AFLIBERCEPT Nummer Datum inwerkingtreding PRESTATIE- EN TARIEFBESCHIKKING ADD-ON AFLIBERCEPT Nummer Datum inwerkingtreding](https://www.pdfsearch.io/img/38a8053e11cf560cbe63f4647b9391df.jpg) | Add to Reading ListSource URL: www.nza.nlLanguage: Dutch - Date: 2015-03-06 04:23:42
|
---|
5![September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea September 16, 2014 EYLEA® (aflibercept) Injection Receives FDA Breakthrough Therapy Designation for Diabetic Retinopathy in Patients with Diabetic Macular Edema Regeneron plans to submit sBLA for this indication by yea](https://www.pdfsearch.io/img/0921ad3316ca7af5aea0831fcd50f7d0.jpg) | Add to Reading ListSource URL: files.shareholder.comLanguage: English |
---|
6![Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Stu Neurotech Announces FDA Acceptance of Investigational New Drug Application and Clinical Trial Initiation of Novel Therapy for Wet AMD Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Stu](https://www.pdfsearch.io/img/539f1b7084ac82e50f019245ef2526a9.jpg) | Add to Reading ListSource URL: www.neurotechusa.comLanguage: English - Date: 2015-03-30 15:27:53
|
---|
7![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Injection For Intra](https://www.pdfsearch.io/img/a3d520b477c46899c4398ec81b2f0118.jpg) | Add to Reading ListSource URL: www.regeneron.comLanguage: English - Date: 2015-04-09 21:19:43
|
---|
8![ZALTRAP® (ziv-aflibercept) ZALTRAP® (ziv-aflibercept)](https://www.pdfsearch.io/img/b718f18238ad0214575daebc5541d494.jpg) | Add to Reading ListSource URL: www.regeneron.comLanguage: English - Date: 2014-11-11 09:09:53
|
---|
9![Ranibizumab / Vascular endothelial growth factor / Bevacizumab / Macular degeneration / Macular edema / Diabetic retinopathy / Laser coagulation / Retina / Low vision / Medicine / Ophthalmology / Vision Ranibizumab / Vascular endothelial growth factor / Bevacizumab / Macular degeneration / Macular edema / Diabetic retinopathy / Laser coagulation / Retina / Low vision / Medicine / Ophthalmology / Vision](/pdf-icon.png) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|
10![Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial, Public Summary Document – November 2014 PBAC Meeting 7.1 AFLIBERCEPT 4 mg/0.1 mL injection, 1 x 0.1 mL vial,](https://www.pdfsearch.io/img/89289dd21b49ba7baa291866664fbf38.jpg) | Add to Reading ListSource URL: www.pbs.gov.auLanguage: English - Date: 2015-03-16 01:05:14
|
---|